BOOK
Unanswered Questions in Periodontology, An Issue of Dental Clinics of North America, E-Book
(2016)
Additional Information
Book Details
Abstract
This issue, edited by Dr. Frank Scannapieco, is devoted to "Unanswered Questions in Periodontology." Review articles will help answer clinical questions such as: Can lost bone in furcations be regenerated?; What biomarkers exist to detect active periodontal disease?; Which mouthrinse products are beneficial for plaque control and gingival health?; Do mobility and occlusal trauma impact periodontal longevity?; Can peri-implantitis be treated?; Is there a genetic basis for periodontitis?; What is the minimal sample size for studies of periodontal treatment?; Does treatment of periodontal disease influence systemic disease?; Does periodontal disease cause cancer?; Is the use of photodynamic therapy beneficial to conventional mechanical therapy in the treatment of periodontitis and peri-implantitis?; Are radiographs the best modality to diagnose and monitor periodontitis?; Does gingival recession require surgical treatment?; and Should antibiotics be prescribed to treat chronic periodontitis?
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Unanswered Questions\rin Periodontology | i | ||
Copyright | ii | ||
Contributors | iii | ||
EDITOR | iii | ||
AUTHORS | iii | ||
Contents | vii | ||
Preface: Unanswered Questions in Periodontology | vii | ||
What is the Contribution of Genetics to Periodontal Risk? | vii | ||
What is the Proper Sample Size for Studies of Periodontal Treatment? | vii | ||
Can Chemical Mouthwash Agents Achieve Plaque/Gingivitis Control? | vii | ||
Is Photodynamic Therapy an Effective Treatment for Periodontal and Peri-Implant Infections? | viii | ||
Is Radiologic Assessment of Alveolar Crest Height Useful to Monitor Periodontal Disease Activity? | viii | ||
Do Mobility and Occlusal Trauma Impact Periodontal Longevity? | viii | ||
Does Treatment of Periodontal Disease Influence Systemic Disease? | viii | ||
Should Antibiotics Be Prescribed to Treat Chronic Periodontitis? | ix | ||
Unanswered Questions: Can Bone Lost from Furcations Be Regenerated? | ix | ||
Can Periimplantitis Be Treated? | ix | ||
Does Gingival Recession Require Surgical Treatment? | ix | ||
DENTAL CLINICS OF NORTH AMERICA | xi | ||
FORTHCOMING ISSUES | xi | ||
January 2016 | xi | ||
April 2016 | xi | ||
July 2016 | xi | ||
RECENT ISSUES | xi | ||
July 2015 | xi | ||
April 2015 | xi | ||
January 2015 | xi | ||
Preface: Unanswered Questions in Periodontology | xiii | ||
What is the Contribution of Genetics to Periodontal Risk? | 761 | ||
Key points | 761 | ||
INTRODUCTION | 761 | ||
PERIODONTITIS IS A COMPLEX DISEASE | 762 | ||
PERIODONTITIS DEVELOPMENT AND PROGRESSION | 764 | ||
SOME THEORETIC BACKGROUND ON GENETICS | 766 | ||
HOW TO IDENTIFY PERIODONTITIS-ASSOCIATED GENETIC MARKERS | 768 | ||
Candidate Gene Approach | 768 | ||
The Genomewide Association Study Approach | 770 | ||
THE BEST REPLICATED AND VALIDATED GENETIC FACTORS FOR PERIODONTITIS | 771 | ||
COX2 on Chromosome 1 | 771 | ||
IL10 on Chromosome 1 | 771 | ||
IL1 Genes on Chromosome 2 | 772 | ||
DEFB1 on Chromosome 8 | 772 | ||
ANRIL on Chromosome 9 | 772 | ||
GLT6D1 on Chromosome 9 | 773 | ||
Other Suggested Periodontitis Genes Based on Genomewide Association Study | 773 | ||
Other Suggested Periodontitis Genes Based on the Candidate Gene Approach | 775 | ||
DISCUSSION AND CONCLUSIONS | 775 | ||
REFERENCES | 776 | ||
What is the Proper Sample Size for Studies of Periodontal Treatment? | 781 | ||
Key points | 781 | ||
INTRODUCTION | 781 | ||
GENERAL REQUIREMENT OF SAMPLE SIZES FOR THE VALIDITY OF STATISTICAL TESTS | 783 | ||
Tests for Categorical Data | 783 | ||
Logistic Regression with Binary Outcomes | 783 | ||
Tests for Numeric Data | 784 | ||
Regression and Analysis of Variance with Numeric Outcomes | 785 | ||
Goodness-of-Fit Testing | 786 | ||
CHARACTERISTIC OF THE DATA IN PERIODONTAL RESEARCH AND THE CORRESPONDING SAMPLING DISTRIBUTIONS | 786 | ||
CAUTION ON USING THE BOOTSTRAP METHOD FOR A SMALL SAMPLE SIZE | 789 | ||
ALTERNATIVE METHODS FOR SMALL SAMPLE SIZES | 790 | ||
Categorical Data Analysis | 790 | ||
Exact Logistic Regression | 791 | ||
Data Analysis with Numeric or Ordinal Data | 791 | ||
Alternatives to Regression Given Small Sample Sizes | 792 | ||
Confidence Intervals | 793 | ||
DISCUSSION | 794 | ||
REFERENCES | 795 | ||
Can Chemical Mouthwash Agents Achieve Plaque/Gingivitis Control? | 799 | ||
Key points | 799 | ||
INTRODUCTION | 800 | ||
MATERIALS AND METHODS | 801 | ||
Focused Question | 801 | ||
Search Strategy | 801 | ||
Screening and Selection | 801 | ||
Inclusion and Exclusion Criteria | 802 | ||
Data Extraction and Assessment of Heterogeneity | 802 | ||
Quality Assessment | 802 | ||
Grading the ‘Body of Evidence’ | 803 | ||
RESULTS | 803 | ||
Search and Selection Results | 803 | ||
Study Outcomes and Assessment of Heterogeneity | 803 | ||
Quality Assessment | 803 | ||
Active Ingredients | 803 | ||
Single Active Ingredients | 804 | ||
Alexidine | 804 | ||
Cetylpyridinium chloride | 816 | ||
Chlorhexidine | 816 | ||
Delmopinol | 817 | ||
Essential oils | 817 | ||
Hexetidine | 818 | ||
Oxygenating agents | 818 | ||
Sanguinarine | 818 | ||
Stannous fluoride | 818 | ||
Triclosan | 819 | ||
Comparisons of Active Ingredients | 819 | ||
Chlorhexidine 0.12% versus chlorhexidine 0.2% | 819 | ||
Essential oils versus chlorhexidine | 819 | ||
Essential oil versus alcohol solution | 819 | ||
Hexetidine versus chlorhexidine | 820 | ||
Oxygenating agents versus chlorhexidine | 820 | ||
Combination of Active Ingredients | 820 | ||
Chlorhexidine and oxygenating agents | 820 | ||
Evidence Profile | 820 | ||
DISCUSSION | 820 | ||
Grading | 822 | ||
Side Effects | 822 | ||
Chlorhexidine and sodium lauryl sulfate | 823 | ||
Substantivity and bioavailability | 823 | ||
Alcohol | 824 | ||
Rinse Duration and Volume | 824 | ||
Limitations of mouthwashes in the prevention of dental plaque formation | 825 | ||
Cost-effectiveness | 826 | ||
SUMMARY | 826 | ||
ACKNOWLEDGMENTS | 826 | ||
REFERENCES | 826 | ||
Is Photodynamic Therapy an Effective Treatment for Periodontal and Peri-Implant Infections? | 831 | ||
Key points | 832 | ||
BIOLOGICAL RATIONALE | 832 | ||
USE OF PHOTODYNAMIC THERAPY AS ADJUNCT TO NONSURGICAL PERIODONTAL THERAPY IN PATIENTS WITH UNTREATED CHRONIC PERIODONTITIS | 833 | ||
USE OF PHOTODYNAMIC THERAPY AS ADJUNCT TO NONSURGICAL PERIODONTAL THERAPY IN PATIENTS WITH AGGRESSIVE PERIODONTITIS | 844 | ||
USE OF PHOTODYNAMIC THERAPY AS AN ADJUNCT TO NONSURGICAL PERIODONTAL THERAPY IN MAINTENANCE PERIODONTITIS PATIENTS | 844 | ||
USE OF PHOTODYNAMIC THERAPY AS AN ALTERNATIVE TO SYSTEMIC OR LOCAL ANTIBIOTICS | 844 | ||
SUMMARY | 854 | ||
CLINICAL RECOMMENDATIONS | 854 | ||
REFERENCES | 855 | ||
Is Radiologic Assessment of Alveolar Crest Height Useful to Monitor Periodontal Disease Activity? | 859 | ||
Key points | 859 | ||
INTRODUCTION | 859 | ||
RADIOGRAPHIC ASSESSMENT OF ALVEOLAR CREST LEVEL | 860 | ||
RADIOGRAPHIC MEASUREMENT OF ALVEOLAR CREST HEIGHT | 865 | ||
LOOKING TOWARD THE FUTURE OF RADIOGRAPHIC ASSESSMENT OF PERIODONTAL DISEASE | 868 | ||
SUMMARY | 870 | ||
ACKNOWLEDGMENTS | 870 | ||
REFERENCES | 870 | ||
Do Mobility and Occlusal Trauma Impact Periodontal Longevity? | 873 | ||
Key points | 873 | ||
HISTORICAL EVIDENCE | 874 | ||
RECENT EVIDENCE: OCCLUSAL TRAUMA AND MOBILITY IMPACT ON PERIODONTITIS PROGRESSION | 875 | ||
POTENTIAL INDICATIONS AND SCIENTIFIC RATIONALE FOR REDUCING OCCLUSAL TRAUMA IN PERIODONTITIS | 876 | ||
IMPACT OF OCCLUSAL TRAUMA ON PERI-IMPLANT BONE LOSS | 876 | ||
CLINICAL CONSIDERATIONS | 877 | ||
ACKNOWLEDGMENTS | 880 | ||
REFERENCES | 880 | ||
Does Treatment of Periodontal Disease Influence Systemic Disease? | 885 | ||
Key points | 885 | ||
INTRODUCTION | 885 | ||
Periodontitis—What Is It? | 886 | ||
SYSTEMIC EFFECTS OF PERIODONTAL INFECTION | 886 | ||
How Does Periodontal Infection Affect Systemic Health? | 886 | ||
Bacteremia | 887 | ||
The oral bacterial burden | 888 | ||
Inflammation | 888 | ||
What is inflammation? | 888 | ||
Inflammation originating in the periodontal microbiome | 889 | ||
Immune response | 889 | ||
SYSTEMIC EFFECTS OF PERIODONTAL TREATMENT | 889 | ||
Effects on Bacterial Load, Inflammation, and Immune Response | 890 | ||
Effects of Periodontal Treatment on Local and Systemic Inflammation | 890 | ||
Bacteremia | 890 | ||
Inflammatory response | 890 | ||
Immune response | 891 | ||
A Special Note on Antibodies (Immune Response) to Periodontal Bacteria | 891 | ||
Gingivitis Treatment Alone Also Has a Positive Effect on Bacterial Load and Inflammation | 891 | ||
Effects on Systemic Diseases | 892 | ||
Diabetes | 892 | ||
Periodontitis: associations with diabetes and prediabetes | 892 | ||
Periodontal infection: effects on blood glucose levels | 892 | ||
How Inflammation Leads to Hyperglycemia—What to Tell the Patient | 895 | ||
Periodontal Treatment in Type 2 Diabetes: Effects on Glycemic Control | 895 | ||
The diabetes and periodontal therapy trial | 896 | ||
Is a reduction of 0.4 percentage points HbA1c clinically meaningful? | 898 | ||
Periodontal Treatment in Prediabetes: Effects on Blood Glucose Levels | 898 | ||
Gingivitis Treatment Only: Effect on Inflammation in Diabetes | 899 | ||
In summary | 899 | ||
Metabolic Syndrome | 899 | ||
Nonalcoholic Fatty Liver Disease | 900 | ||
In summary | 900 | ||
Cerebrocardiovascular Disease | 900 | ||
Bacteremia | 900 | ||
Inflammation | 901 | ||
Periodontal treatment: effect on cardiovascular diseases and events | 901 | ||
Periodontal treatment: effects on risk factors for cardiovascular events | 901 | ||
Periodontal treatment: effect on intima media thickness and endothelial dysfunction | 902 | ||
Rheumatoid Arthritis | 902 | ||
Gingivitis treatment alone: effect on rheumatoid arthritis manifestation | 903 | ||
In summary | 903 | ||
Respiratory Tract Diseases | 903 | ||
Aspiration pneumonia | 903 | ||
Ventilator-assisted pneumonia | 904 | ||
Chronic obstructive pulmonary disease | 904 | ||
Chronic Kidney Disease | 904 | ||
Periodontal treatment: effect on chronic kidney disease | 904 | ||
In summary | 904 | ||
Cancer | 905 | ||
In summary | 905 | ||
Other Diseases | 905 | ||
Obesity | 906 | ||
Pregnancy | 906 | ||
Why It Is so Difficult to Determine Whether Periodontal Treatment Has Systemic Effects | 906 | ||
SUMMARY | 907 | ||
REFERENCES | 908 | ||
Should Antibiotics Be Prescribed to Treat Chronic Periodontitis? | 919 | ||
Key points | 919 | ||
INTRODUCTION | 919 | ||
PATIENT EVALUATION FOR POTENTIAL USE OF AN ANTIBIOTIC: OVERVIEW | 922 | ||
EFFICACY OF SCALING AND ROOT PLANING AS THE SOLE TREATMENT OF PERIODONTITIS | 923 | ||
EFFICACY OF SYSTEMIC ANTIBIOTICS AS THE SOLE TREATMENT OF PERIODONTITIS | 923 | ||
EFFICACY OF SCALING AND ROOT PLANING COMBINED WITH SYSTEMIC ANTIBIOTICS | 924 | ||
TREATMENT COMPLICATIONS AND RESISTANCE | 925 | ||
EVALUATION OF OUTCOME AND LONG-TERM RECOMMENDATIONS | 929 | ||
SUMMARY | 929 | ||
REFERENCES | 930 | ||
Unanswered Questions | 935 | ||
Key points | 935 | ||
INTRODUCTION | 935 | ||
DIAGNOSIS AND CLASSIFICATION OF FURCATION DEFECTS | 936 | ||
TREATMENT OF FURCATION DEFECTS | 937 | ||
THE PROBLEM WITH PROBING | 937 | ||
POUCHES WITHIN FURCATIONS | 938 | ||
TYPES OF EVIDENCE FOR NEW BONE GROWTH IN FURCATION DEFECTS | 938 | ||
HISTOLOGIC EVIDENCE FOR NEW BONE GROWTH IN FURCATION DEFECTS IN ANIMAL MODELS | 940 | ||
HISTOLOGIC EVIDENCE FOR NEW BONE GROWTH IN HUMAN FURCATION DEFECTS | 942 | ||
EVIDENCE FOR NEW BONE GROWTH IN HUMAN FURCATION DEFECTS OBTAINED BY SURGICAL REENTRY | 944 | ||
PERIODONTAL REGENERATION | 946 | ||
SUMMARY | 947 | ||
REFERENCES | 947 | ||
Can Periimplantitis Be Treated? | 951 | ||
Key points | 951 | ||
INTRODUCTION | 951 | ||
Definition | 952 | ||
Diagnosis | 952 | ||
Classification | 953 | ||
Epidemiology | 954 | ||
Goals of Treatment | 954 | ||
CONTROL OF CONTRIBUTING FACTORS | 954 | ||
Patient-Related Factors | 954 | ||
Smoking | 954 | ||
Periodontal status | 955 | ||
Implant-Related Factors | 955 | ||
Implant position | 955 | ||
Prosthetic considerations | 958 | ||
THERAPEUTIC OPTIONS AND THEIR CLINICAL OUTCOMES | 959 | ||
Nonsurgical Interventions | 959 | ||
Antiinfective measures | 959 | ||
Mechanical debridement | 959 | ||
Chemotherapeutics | 959 | ||
Lasers | 961 | ||
Summary | 961 | ||
Surgical Interventions | 961 | ||
Access flap | 967 | ||
Resective and regenerative | 967 | ||
Summary | 969 | ||
PROPOSED WORKFLOW | 969 | ||
SUMMARY | 971 | ||
REFERENCES | 972 | ||
Does Gingival Recession Require Surgical Treatment? | 981 | ||
Key points | 982 | ||
INTRODUCTION | 982 | ||
ETIOLOGY | 983 | ||
Predisposing Factors | 983 | ||
Precipitating Factors | 984 | ||
PATHOGENESIS OF GINGIVAL RECESSION | 986 | ||
FACTORS TO BE CONSIDERED FOR TREATING GINGIVAL RECESSION | 987 | ||
Classification of Recession Defects | 987 | ||
Patient’s Concerns | 987 | ||
Unsatisfactory esthetics | 989 | ||
Root hypersensitivity | 989 | ||
Active Recession (Progression) | 990 | ||
Restorative or Orthodontic Needs | 990 | ||
TREATMENT GOALS | 990 | ||
TREATMENT OUTCOMES OF VARIOUS SURGICAL PROCEDURES | 991 | ||
SUMMARY AND FINAL REMARKS | 992 | ||
REFERENCES | 993 | ||
Index | 997 |